SCHEMBL1129847

SCHEMBL1129847

CC(C)(C)SCCCCSc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
MAPT P10636 3/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
EHMT2 Q96KQ7 1/20 0.42
EHMT1 Q9H9B1 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.41
GRM2 Q14416 1/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129373 0.98 ALDH1A1 (0.47) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL1130079 0.98 ALDH1A1 (0.47) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL1130288 0.97 ALDH1A1 (0.49) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL1743693 0.81 ALDH1A1 (0.53) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL15271423 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL15271663 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL15270700 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
Ammonia Solution, Strong SCHEMBL1743339 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL15270973 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL10723137 0.79 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190077894-A1 PROCESS FOR PREPARING CATALYSTS LANXESS DEUTSCHLAND GMBH (DE) 2019-03-14 US disclosed
EP-2952256-B1 METHOD FOR THE PRODUCTION OF CATALYSTS LANXESS DEUTSCHLAND GMBH (DE) 2017-05-17 EP disclosed
US-20150353660-A1 PROCESS FOR PREPARING CATALYSTS LANXESS DEUTSCHLAND GMBH (DE) 2015-12-10 US disclosed
EP-2952256-A1 METHOD FOR THE PRODUCTION OF CATALYSTS LANXESS Deutschland GmbH (DE) 2015-12-09 EP disclosed
US-8932976-B2 Preparation of catalyst for bisphenols production DOW GLOBAL TECHNOLOGIES LLC (US) 2015-01-13 US disclosed
EP-2158040-B1 PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION DOW GLOBAL TECHNOLOGIES INC (US) 2011-02-16 EP disclosed
US-20100152028-A1 PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION DOW GLOBAL TECHNOLOGIES LLC 2010-06-17 US disclosed
EP-2158040-A1 PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION Dow Global Technologies Inc. (US) 2010-03-03 EP disclosed
WO-2008157025-A1 PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION DOW GLOBAL TECHNOLOGIES INC. (US) 2008-12-24 WO disclosed
US-6995294-B2 Method for producing bisphenol catalysts and bisphenols GENERAL ELECTRIC COMPANY (US) 2006-02-07 US disclosed
US-6992228-B2 Method for producing bisphenol catalysts and bisphenols GENERAL ELECTRIC COMPANY (US) 2006-01-31 US disclosed
US-20050090696-A1 Method for producing bisphenol catalysts and bisphenols SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2005-04-28 US disclosed
US-20050090697-A1 Method for producing bisphenol catalysts and bisphenols SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2005-04-28 US disclosed
US-6884894-B2 Method for producing bisphenol catalysts and bisphenols GENERAL ELECTRIC COMPANY (US) 2005-04-26 US disclosed
US-6872860-B1 Method for producing bisphenol catalysts and bisphenols GENERAL ELECTRIC COMPANY (US) 2005-03-29 US disclosed
US-6620939-B2 Reacting phenol and acetone in the presence of acid catalysts or promoters such as 2-(3'-tert-butylthiopropylthioethyl)-pyridine on catalyst supports, to form isopropylidenediphenol; stereospecific GENERAL ELECTRIC COMPANY 2003-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090697-A1 Method for producing bisphenol catalysts and bisphenols GSTP1, PCBP1, GSTA2 ALDH1A1 1497/4885MAPT 3547/4885KMT2A 1007/4885
US-20050090696-A1 Method for producing bisphenol catalysts and bisphenols GSTP1, PCBP1, GSTA2 ALDH1A1 1497/4885MAPT 3547/4885KMT2A 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.